Colorectal News and Research

RSS

CHLA conference connects families navigating childhood bladder exstrophy

Children's Hospital Los Angeles hosted the annual Association for the Bladder Exstrophy Community (ABEC) conference, bringing together nearly 100 patients and families from across the country and globe.

6 Nov 2026

Philanthropists donate $6 million to establish the UVA Biotech Innovation Fund

The University of Virginia Paul and Diane Manning Institute of Biotechnology received gifts totaling $6 million from philanthropists to establish the UVA Biotech Innovation Fund.

6 Nov 2026

Vulnerable DNA sites make cancer cells sensitive to PARP inhibitors

A small subset of vulnerable DNA sites can make cancer cells highly sensitive to targeted drugs called PARP inhibitors, a new study shows.

5 Nov 2026

Rising colorectal cancer rates prompt earlier routine screening recommendations

Forty-five is the new 60 – at least when it comes to colonoscopies. That may not be the party you look forward to, but it could save your life. According to the Cancer Research Institute, 1 in 5 colorectal cancers are diagnosed in patients under age 55, making what was once thought of as an older person's disease one of the fastest-growing cancers in young people.

5 Nov 2026

Protein DUSP4 prevents immune cell exhaustion in colorectal cancer

The immune system has powerful cells that can recognize and destroy cancer, but this ability can gradually wane when the cells reside within a tumor.

4 Nov 2026

Blood may reveal signs of gut-related disease that stool samples miss

In a study of 193 participants, researchers found that blood-based short-chain fatty acid profiles distinguished colorectal cancer, celiac disease, obesity, and healthy controls with 95% accuracy, compared with 59% for stool-based measurements. Combining blood and stool profiles increased accuracy to 97%, suggesting that circulating microbial metabolites may offer valuable diagnostic information, although larger studies are needed to validate the findings.

3 Nov 2026

Aspirin fails to prevent recurrence after surgery for colorectal cancer liver metastases

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.

2 Nov 2026

New strategy exploits a hidden genetic vulnerability in multiple cancers

Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine.

2 Nov 2026

New study reveals why colorectal cancer is more aggressive in youth

Dana-Farber Cancer Institute researchers, along with Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, and the Broad Institute, have uncovered biological clues to why colorectal cancer can behave more aggressively in younger people.

29 Oct 2026

Machine learning models predict common cancer risks using routine health data

Machine learning models using routinely collected health information, such as blood tests, medical history and lifestyle factors, could help identify people at higher risk of several common cancers, according to an international study reported at the ESMO Congress 2026.

27 Oct 2026

Beer and liquor show more oral bacteria links than wine in a large US study

Researchers analyzed beverage intake and oral microbiome data from 5,598 adults across three US cohorts and found that alcohol consumption showed the strongest associations with oral bacterial diversity and composition among the beverages examined. Higher alcohol intake was associated with greater bacterial richness and differences in genera linked to oral health, but the cross-sectional preprint could not establish whether alcohol caused these differences or influenced disease risk.

26 Oct 2026

Friends play a direct role in encouraging regular cancer screening

Friends may play a direct role in whether people keep up with cancer screening regularly, while family influence appears to operate more through knowledge and attitudes towards screening, according to new research by Singapore Management University's (SMU) Center for Research on Successful Ageing (ROSA).

26 Oct 2026

Phase 3 EMT2 trial demonstrates survival benefit for high-dose EPA

Patients assigned to receive high-dose eicosapentaenoic acid (EPA), an omega-3 fatty acid, before and after surgery for colorectal cancer liver metastases had longer overall survival than those assigned to receive placebo, according to results of the phase 3 EMT2 trial presented at the ESMO Congress 2026.

26 Oct 2026

Study identifies potential new ways to treat the most common type of bowel cancer

Major new research published today identifies potential new ways to treat the most common type of bowel cancer in Ireland.

23 Oct 2026

FDA grants accelerated approval to groundbreaking rectal cancer immunotherapy

A groundbreaking immunotherapy treatment for rectal cancer, developed through pioneering research at Memorial Sloan Kettering Cancer Center (MSK) with critical early-stage funding from Swim Across America, has received accelerated approval from the U.S. Food and Drug Administration (FDA).

22 Oct 2026

BGI Genomics smarter stool testing detects colorectal cancer across Latin America

BGI Genomics' COLOTECT® addresses colorectal cancer in LATAM through innovative non-invasive screening, enhancing early detection and treatment efficiency.

From BGI Genomics 22 Oct 2026

Operating room air purification fails to reduce surgical infections

A study of more than 110,000 surgeries found that adding advanced air purification and sterilization systems to operating rooms did not reduce surgical site infections, postoperative complications, or deaths.

20 Oct 2026

Not all ultra-processed foods show the same cancer risk

Ultra-processed foods show varied associations with colorectal cancer, underscoring the need for precise research on diet quality and cancer risk factors.

20 Oct 2026

Presurgical sleep medications linked to less pain and anxiety after surgery

Improving sleep before surgery through the use of melatonin or Ambien (zolpidem) may ease presurgical anxiety, reduce pain after surgery, decrease opioid requirements and help patients recover better, according to an analysis of 25 years of research presented at the ANESTHESIOLOGY® 2026 annual meeting.

19 Oct 2026

CSHL researchers find way to make immunotherapy effective against colorectal cancer

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

14 Oct 2026